MedTrace Logo

Preterm Birth Cohort Study in Guangzhou

NCT03668327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-02-26

No results posted yet for this study

Summary

The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.

Conditions

  • Preterm Birth
  • Neurodevelopment
  • Immune Development
  • Host and Microbiome

Interventions

OTHER

Sponsors & Collaborators

  • Guangzhou Women and Children's Medical Center

    lead OTHER

Principal Investigators

  • Xiu Qiu, MD,PhD · Guangzhou Women and Children's Medical Center, China

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-01
Primary Completion
2025-12-31
Completion
2038-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03668327 on ClinicalTrials.gov